Repaglinide has more beneficial effect on cardiovascular risk factors than glimepiride: data from meal-test study
Author:
Publisher
Elsevier BV
Subject
Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference22 articles.
1. Control of post-prandial hyperglycemia-an essential part of good diabetes treatment and prevention of cardiovascular complications;Hanefeld;Nutr Metab Cardiovasc Dis,2002
2. Epidemiology of risk factors for cardiovascular disease in diabetes and impaired glucose tolerance;Laakso;Atherosclerosis,1998
3. Repaglinide and related hypoglycemic benzoic acid derivatives;Grell;J Med Chem,1998
4. A comparison of repaglinide and glibenclamide in the treatment of type 2 diabetic patients previously treated with sulphonylureas;Landgraf;Eur J Clin Pharmacol,1999
5. Increased prandial insulin secretion following a single preprandial oral dose of repaglinide in patients with type 2 diabetes;Owens;Diabetes Care,2000
Cited by 27 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Efficacy and Cardiovascular Safety of Meglitinides;Current Drug Safety;2021-06-08
2. Comment on: Nonesterified fatty acids and risks of frailty, disability, and mobility limitation in older adults: The cardiovascular health study;Journal of the American Geriatrics Society;2021-04-15
3. Heart failure risk and major cardiovascular events in diabetes: an overview of within-group differences in non-insulin antidiabetic treatment;Heart Failure Reviews;2018-01-10
4. Phospholipid complex enriched micelles: A novel drug delivery approach for promoting the antidiabetic effect of repaglinide;European Journal of Pharmaceutical Sciences;2017-03
5. Comparing the risks of hospitalized heart failure associated with glinide, sulfonylurea, and acarbose use in type 2 diabetes: A nationwide study;International Journal of Cardiology;2017-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3